Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 12/20 | 1.00 |
| ▸ | HTT | P42858 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.75 |
| ▸ | PKM | P14618 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | MET | P08581 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29558135 | 1.00 | HTR6 (1.00) | HTR6HTTMEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL28794299 | 0.98 | HTR6 (0.96) | HTR6HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL31663420 | 0.90 | HTR6 (0.81) | HTR6HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL9587047 | 0.86 | HTR6 (0.75) | HTR6HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL3967709 | 0.86 | HTR6 (0.75) | HTR6HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL29414854 | 0.86 | HTR6 (0.75) | HTR6HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL1673252 | 0.86 | HTR6 (0.75) | HTR6HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL4862697 | 0.86 | HTT (1.00) | HTR6HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL1203289 | 0.84 | HTR6 (0.73) | HTR6HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL30625044 | 0.84 | HTR6 (0.72) | HTR6HTTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11384076-B2 | Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitors | UNIVERSITÄT REGENSBURG (DE) | 2022-07-12 | — | — | US | claimed |
| CN-101258144-B | As a functional 5-HT6Aminoarylsulfonamide derivatives of ligands | SUVEN LIFE SCIENCES LTD | 2012-05-30 | — | — | CN | claimed |
| CN-101258144-A | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands | SUVEN LIFE SCIENCES LTD (IN) | 2008-09-03 | — | — | CN | claimed |
| US-20060222997-A1 | Adhesion improver for photosensitive resin composition and photosensitive resin composition containing same | KOBAYASHI SATOSHI | 2006-10-05 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-6106599-A | Inks | XEROX CORPORATION (US) | 2000-08-22 | — | — | US | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| CN-1033276-A | Biphenyl derivatives and method for making thereof | TANABE SEIYAKU CO (JP) | 1989-06-07 | — | — | CN | claimed |
| EP-0316939-A2 | Biphenyl derivatives, preparation method, pharmaceutical compositions comprising them and use | Tanabe Seiyaku Co., Ltd. (JP) | 1989-05-24 | — | — | EP | claimed |
| JP-4273857-A | — | — | None | — | — | JP | disclosed |
| US-12630511-B2 | Benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-05-19 | — | — | US | disclosed |
| CN-116891461-B | Synthesis method of SERD intermediate | 罗欣药业(上海)有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-0070698-B1 | HERBICIDAL INDOLE SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-11-13 | — | — | EP | disclosed |
| EP-0135781-A1 | 3-(Piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles, a process for their preparation and their use as a medicament | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1985-04-03 | — | — | EP | disclosed |
| US-4404277-A | CYANINE DYES, SILVER HALIDE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-09-13 | — | — | US | disclosed |
| EP-0070698-A1 | Herbicidal indole sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384076-B2 | Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitors | FLT3, CSF3R, ABL1 | HTR6 3062/4885HTT 4235/4885MEN1 1639/4885 |
| US-12630511-B2 | Benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer | EGFR, ERBB2, KRAS | HTR6 1150/4885HTT 4213/4885MEN1 2435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.